Ceruloplasmin Status in Medullary Thyroid Carcinoma

  • Fatemeh RAZAVI 1. Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran 2. Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  • Sara SHEIKHOLESLAMI Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medi-cal Sciences, Tehran, Iran
  • Marjan ZARIF YEGANEH Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medi-cal Sciences, Tehran, Iran
  • Tahereh NAJI Pharmaceutical Sciences Branch, Islamic Azad University, Tehran, Iran
  • Mehdi HEDAYATI Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medi-cal Sciences, Tehran, Iran

Abstract

No Abstract

References

1. Gilliand F, Hunt W, Orris D, Key C (1997). Prognostic factors for thyroid carcinoma: a population based study of 15,698 cases from the surveillance, epidemiology and end results (SEER) program 1973-1991. Cancer, 79:564-73.
2. Nozhat Z, Hedayati M (2016). Medullary thyroid carcinoma: a review on ethical considerations in treatment of children. J Pediatr Endocrinol Metab, 29(6):633-9.
3. Arner E, Forrest AR, Ehrlund A et al (2014). Ceruloplasmin is a novel adipokine which is overexpressed in adipose tissue of obese subjects and in obesity-associated cancer cells. PLoS One, 9(3):e80274.
4. Jabbari S, Hedayati M, Yaghmaei P, Parivar K (2015). Medullary Thyroid Carcinoma—Circulating Status of Vaspin and Retinol Binding Protein-4 in Iranian Patients. Asian Pac J Cancer Prev, 16(15):6507-12.
5. Abooshahab R, Yaghmaei P, Ghadaksaz HG, Hedayati M (2016). Lack of Association between Serum Adiponectin/Leptin Levels and Medullary Thyroid Cancer. Asian Pac J Cancer Prev, 17(8):3861-4.
Published
2020-01-08
How to Cite
1.
RAZAVI F, SHEIKHOLESLAMI S, ZARIF YEGANEH M, NAJI T, HEDAYATI M. Ceruloplasmin Status in Medullary Thyroid Carcinoma. Iran J Public Health. 49(1):209-210.
Section
Letter to the Editor